SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Supergen (supg)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: W Shakespeare who wrote (80)5/18/1999 8:11:00 PM
From: Russian Bear  Read Replies (1) of 124
 
Yes, I agree.

They are going to need more money relatively soon, and lots of it. I have to assume that partnering 9-nc does not fit into Dr. Rubinfeld's empire-building plans. That only leaves public financing of one type or another (unless, of course, they can tap that mystery bank of theirs again.)

Peter S. appears to have confidence that they will be able to secure the needed capital on reasonable terms and avoid excessive dilution. (And I hope that you are right, Peter!) But I will feel more comfortable buying in after their cash situation clarifies, even if that luxury costs me rather dearly.

The drug itself is quite intriguing: 1. Pancreatic represents a very easy FDA hurdle to clear; 2. Reasonable expectation for broad applications (i.e., off label revenues;) 3. Potential for dramatic synergy with other agents.

RB
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext